According to Rongchang Biotech's announcement, Wang Weidong, the actual controller and chairman, proposed that the company use its own funds and/or self-raised funds to repurchase A shares through centralized bidding transactions. The total repurchase capital is not less than RMB 30 million and not more than RMB 60 million. The price is not higher than 150% of the average transaction price of the company's A shares in the 30 trading days before the board of directors passed the buyback resolution. The repurchase of shares is intended to protect the company's value and shareholders' rights. It is planned to be sold 12 months after disclosure of the repurchase results and share change report announcement, and completed within 3 years after disclosure of the repurchase results and share change announcements. The repurchase period is within 3 months from the date the board of directors reviews and approves the repurchase plan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.